- Title
- CD70 is a potential target biomarker in peripheral T-cell lymphomas
- Creators
- Mario L Marques-Piubelli - The University of Texas MD Anderson Cancer CenterJason Sagert - CRISPR TherapeuticsMinh Thu Pham - CRISPR TherapeuticsMatthias Will - CRISPR TherapeuticsDan Henderson - CRISPR TherapeuticsKimberly Tipton - CRISPR TherapeuticsSwaminathan Iyer - The University of Texas MD Anderson Cancer CenterWei Lu - The University of Texas MD Anderson Cancer CenterKhaja B Khan - The University of Texas MD Anderson Cancer CenterLeticia Hamana - The University of Texas MD Anderson Cancer CenterJennifer R Chapman - Jackson Memorial HospitalBeenu Thakral - The University of Texas MD Anderson Cancer CenterJie Xu - The University of Texas MD Anderson Cancer CenterRoberto N Miranda - The University of Texas MD Anderson Cancer CenterKristofer Jennings - The University of Texas MD Anderson Cancer CenterLuisa M Solis - The University of Texas MD Anderson Cancer CenterFrancisco Vega - The University of Texas MD Anderson Cancer Center
- Publication Details
- Histopathology, Vol.81(2), pp.272-275
- Academic Unit
- Miller School of Medicine; UMMG Department of Pathology
- Language
- English
- Resource Type
- Journal article
- PMID
- 35474464
- Record Identifier
- 991031740160902976
Journal article
CD70 is a potential target biomarker in peripheral T-cell lymphomas
Histopathology, Vol.81(2), pp.272-275
2022-04-26
PMID: 35474464
Metrics
2 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.1464 HTLV-1
- Web Of Science research areas
- Cell Biology
- Pathology
- ESI research areas
- Biology & Biochemistry
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites